• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation

  • in Public Health
  • — 5 Mar, 2007
Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation
AudioMedica News
Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation
Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-242"/>
Chloe Thio

CHLOE THIO, Johns Hopkins University School of Medicine

REFERENCE: Abstract: 136LB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
Entecavir, used to treat hepatitis B virus infections, can lower levels of HIV in co-infected patients but also selects for a mutation that makes HIV resistant to entecavir as well as the antiretroviral drugs lamivudine and emtricitabine. These findings, derived from three case reports and associated laboratory studies, have important implications for the treatment of HBV in HIV-infected patients. Current guidelines, issued in October 2006 and which recommend entecavir as a first-line treatment of HBV in co-infected individuals who do not require anti-HIV therapy, need to be reconsidered. Chloe Thio discussed her study results and their implications with Dan Keller at the 14th Conference on Retroviruses and Opportunistic Infections in Los Angeles.

[audio:https://www.audiomedica.com/podcasting/global_health/070306_chloe_thio.mp3]

You may also like...

  • New "Point Of Care" TB Tests Urgently Needed! New “Point Of Care” TB Tests Urgently Needed! 17 Aug, 2009
  • Peter Piot World AIDS Day: Towards A Sustained Strategic Response To Fight AIDS 3 Dec, 2010
  • Hugh Reyburn Lab In A Box Fights Malaria In The Villages 12 Nov, 2011
  • Sharon Huttly London School of Hygiene & Tropical Medicine Celebrates Distance Learning Success 29 May, 2010

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Oncology in Advance – March 1st, 2007
  • Next story Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Childhood Obesity—Whose Business Is It?
    • Which Tasks Most Influence Pediatric PT…
    • New Front Line Standard for Older Patients with…
  • Home
  • Public Health
  • Entecavir Shows Activity Against HIV But Also Selects for an Antiretroviral Drug Resistance Mutation

© COPYRIGHT 2020 AUDIOMEDICA.COM.